TITLE

COMMENTARY: A quadrivalent vaccine against human papillomavirus prevented anogenital diseases in young women

AUTHOR(S)
Andrews, Jeff
PUB. DATE
November 2007
SOURCE
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p71
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author reflects upon a study evaluating the effectiveness of quadrivalent vaccine against human papillomavirus (HPV), in preventing anogenital diseases in young women. He comments on the limited length of the study's follow-ups and suggests the requirement of longer follow-up for evaluating durability of immunization and vaccine's benefits for cancer. He also remarks on the selected age range of the study and the efficacy of the vaccine on aged women.
ACCESSION #
28019881

 

Related Articles

  • A quadrivalent vaccine against human papillomavirus prevented anogenital diseases in young women.  // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p71 

    The article focuses on a clinical study investigating the effectiveness of quadrivalent vaccine against human papillomavirus (HPV) in preventing anogenital diseases in young women. It discusses the selection criteria of the participants, follow up period, and the randomized controlled trials,...

  • Women look for fast relief from yeast infections. Rosendahl, Iris // Drug Topics;7/10/95, Vol. 139 Issue 13, p47 

    Presents a study which said that rapid symptomatic relief with minimal side effects is the most important consideration for women using yeast infection medication. Recommendation by a physician as most important factor cited by women, followed by rapid cure.

  • HPV4 not associated with autoimmune conditions. Foster, Melissa // Hem/Onc Today;10/10/2010, Vol. 11 Issue 19, p17 

    This article focuses on a study which investigated the safety of the quadrivalent human papillomavirus (HPV) vaccine.

  • HPV4 not associated with autoimmune conditions. Foster, Melissa // Hem/Onc Today;10/10/2010, Vol. 11 Issue 19, p17 

    This article discusses a study which examined the safety of the quadrivalent human papillomavirus (HPV) vaccine.

  • SECTION 15: OB/GYN.  // Physician Assistants' Prescribing Reference;Fall2010, Vol. 17 Issue 3, p213 

    The article lists several drugs used for female reproductive system which include the injectable contraceptive Depo-Provera from Pfizer, the antidysmenorrhea Anaprox from Roche, Aygestin for endometriosis from Duramed.

  • Just say `wait a minute.' Perlmutter, Cathy; Hanlon, Toby // Prevention;Jan98, Vol. 50 Issue 1, p94 

    Focuses on the use of hysterectomies to correct reproductive tract-linked problems in women in the United States. Problems include fibroid tumors and endometriosis; When a hysterectomy is inappropriate. INSETS: Weighing the decision.;When you do need a hysterectomy.;When is a hysterectomy...

  • I wish I'd shaved my legs. Cowin, Ged // Australian Nursing Journal;May2002, Vol. 9 Issue 10, p40 

    Presents an article on becoming a day surgery patient for a gynecological procedure. Concern over whether or not to take off underwear; Anxiety in relation to the tests conducted; Support given by the nurse.

  • Diagnosis and Treatment of Endometriosis. Wellbery, Caroline // American Family Physician;10/15/1999, Vol. 60 Issue 6, p1753 

    Elaborates on the diagnosis and treatment of endometriosis. Epidemiology; Pathogenesis; Clinical features and diagnostic evaluation.

  • HPV vax uptake remains low in US, despite being "safe and effective".  // PharmacoEconomics & Outcomes News;Aug2014, Vol. 708 Issue 1, p6 

    The article discusses a research on human papillomavirus (HPV) vaccination in the U.S., in reference to the study "HPV vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014 - United States," by S. Stokley, et al., which appeared in the July 25,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics